Literature DB >> 18672138

The Genetic Information Nondiscrimination Act: why your personal genetics are still vulnerable to discrimination.

Louise M Slaughter1.   

Abstract

Genetic research offers great potential for early treatment and the prevention of numerous diseases. As technology continues to advance, ethical, legal, and social challenges continue to present themselves. The Genetic Information Nondiscrimination Act (GINA) looks to protect an individual's genetic information from employer and insurance discrimination while encouraging Americans to take advantage of genetic testing to prevent and prepare for potential diseases. GINA will do more than stamp out a new form of discrimination: it will help the United States be a leader in a field of scientific research that holds as much promise as any other in history.

Entities:  

Mesh:

Year:  2008        PMID: 18672138     DOI: 10.1016/j.suc.2008.04.004

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  9 in total

Review 1.  A systematic review of strategies that increase the recruitment and retention of African American adults in genetic and genomic studies.

Authors:  Vanessa A Johnson; Yolanda M Powell-Young; Elisa R Torres; Ida J Spruill
Journal:  ABNF J       Date:  2011

Review 2.  Autosomal dominant polycystic kidney disease: the last 3 years.

Authors:  Vicente E Torres; Peter C Harris
Journal:  Kidney Int       Date:  2009-05-20       Impact factor: 10.612

Review 3.  Ethical issues of predictive genetic testing for diabetes.

Authors:  Susanne B Haga
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

4.  Self diagnosis of Lynch syndrome using direct to consumer genetic testing: a case study.

Authors:  Maegan E Roberts; Douglas L Riegert-Johnson; Brittany C Thomas
Journal:  J Genet Couns       Date:  2011-03-30       Impact factor: 2.537

5.  Impact of gene patents and licensing practices on access to genetic testing for long QT syndrome.

Authors:  Misha Angrist; Subhashini Chandrasekharan; Christopher Heaney; Robert Cook-Deegan
Journal:  Genet Med       Date:  2010-04       Impact factor: 8.864

Review 6.  Confidentiality & the Risk of Genetic Discrimination: What Surgeons Need to Know.

Authors:  Amanda Gammon; Deborah W Neklason
Journal:  Surg Oncol Clin N Am       Date:  2015-07-16       Impact factor: 3.495

7.  Ethical concerns related to developing pharmacogenomic treatment strategies for addiction.

Authors:  Alexandra E Shields
Journal:  Addict Sci Clin Pract       Date:  2011-07

8.  Qualitative thematic analysis of consent forms used in cancer genome sequencing.

Authors:  Clarissa Allen; William D Foulkes
Journal:  BMC Med Ethics       Date:  2011-07-19       Impact factor: 2.652

Review 9.  Engaging pharmacogenomics in pain management and opioid selection.

Authors:  David R Bright; Natasha Petry; Eric Roath; Tyler Gibb
Journal:  Pharmacogenomics       Date:  2021-09-15       Impact factor: 2.638

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.